The University of Chicago Header Logo

Connection

Sandeep Gurbuxani to Primary Myelofibrosis

Back to Details
This is a "connection" page, showing publications Sandeep Gurbuxani has written about Primary Myelofibrosis.
Sandeep Gurbuxani
Connection Strength
2.237
Primary Myelofibrosis
  1. SETBP1 sets the stage. Blood. 2024 04 04; 143(14):1323-1324.
    View in: PubMed
    Score: 0.899
  2. CXCL4's "Gliful" subversion of BM in MPN. Blood. 2020 10 29; 136(18):1999-2000.
    View in: PubMed
    Score: 0.709
  3. IL-13/IL-4 signaling contributes to fibrotic progression of the myeloproliferative neoplasms. Blood. 2022 12 29; 140(26):2805-2817.
    View in: PubMed
    Score: 0.206
  4. Aurora Kinase A Inhibition Provides Clinical Benefit, Normalizes Megakaryocytes, and Reduces Bone Marrow Fibrosis in Patients with Myelofibrosis: A Phase I Trial. Clin Cancer Res. 2019 Aug 15; 25(16):4898-4906.
    View in: PubMed
    Score: 0.160
  5. Downregulation of GATA1 drives impaired hematopoiesis in primary myelofibrosis. J Clin Invest. 2017 Apr 03; 127(4):1316-1320.
    View in: PubMed
    Score: 0.137
  6. Targeting megakaryocytic-induced fibrosis in myeloproliferative neoplasms by AURKA inhibition. Nat Med. 2015 Dec; 21(12):1473-80.
    View in: PubMed
    Score: 0.126
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.